Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2025-12-25 @ 1:03 AM
NCT ID:
NCT02312193
Eligibility Criteria:
Inclusion Criteria:
* Males or females between 30 and 70 years of age
* Hypertensive patients: Patients with a previous diagnosis of hypertension
* Normotensive patients: subjects without story of hypertension
* Written informed consent
Exclusion Criteria:
* Severe hypertension (eg, systolic \>180 mm Hg, diastolic \>110 mm Hg)
* Manifested or suspected secondary hypertension (coarctation of the aorta, hyperaldosteronism, unilateral or bilateral renal artery stenosis, pheochromocytoma)
* History of cardiac complications (previous acute myocardial infarction (AMI), unstabile angina, percutaneous transluminal coronary angioplasty (PTCA), coronary artery bypass grafting (CABG), congestive heart failure (NYHA II-IV))
* Diabetes mellitus
* Renal pathologies (creatinine clearance \< 30 ml/min)
* Severe hepatic dysfunction
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
70 Years
Study:
NCT02312193
Study Brief:
Protocol Section:
NCT02312193